DermBiont

DermBiont’s mission is to become the world’s leading precision dermatology company developing targeted topical therapeutics that treat, cure, and prevent diseases. DermBiont’s biotherapeutics discovery team leverages computational biology and a proprietary bioinformatics platform to identify clinically meaningful dysbiosis related to common skin diseases, and mines a curated library of microbes to build a pipeline of products to treat identified dysbiosis across indications. The company aims to impact the root causes of skin diseases through the development of targeted small molecule therapeutics with well-defined mechanisms of action and with biotherapeutics that repair imbalances of the microbiome.